Remote Patient Monitoring Market to Hit $62.2B by 2031, Driven by Hospital-at-Home Expansion
Event summary
- The global remote patient monitoring (RPM) market is projected to grow from $34.5B in 2026 to $62.2B by 2031, a 12.5% CAGR.
- Growth is driven by rising chronic disease prevalence, expanding hospital-at-home programs, and reimbursement-supported remote monitoring.
- AI-enabled monitoring platforms are shifting from passive tracking to predictive care, reducing manual review burdens on clinical staff.
- Cellular-connected devices are simplifying patient onboarding, accelerating adoption among elderly and non-technical patients.
- Key players include Koninklijke Philips N.V., Abbott Laboratories, and Oracle Corporation, focusing on innovation and strategic partnerships.
The big picture
The remote patient monitoring market is experiencing significant growth due to the expansion of hospital-at-home care models and the increasing prevalence of chronic diseases. The shift from passive tracking to predictive care, enabled by AI and cellular-connected devices, is transforming how healthcare providers manage chronic conditions and reduce hospital readmissions. This trend is supported by dedicated CMS reimbursement codes and the need to address workforce shortages and clinical burnout.
What we're watching
- Regulatory Scrutiny
- The U.S. Department of Health and Human Services' Office of Inspector General is intensifying scrutiny of RPM-related billing, which could impact market growth.
- Interoperability Challenges
- Integrating RPM systems with existing hospital IT and electronic health record workflows remains a persistent operational bottleneck.
- Market Expansion
- Asia-Pacific is the fastest-growing region, driven by expanding digital health infrastructure and rising chronic disease prevalence.